Cargando…

Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway

Osteosarcoma is the most common cause of cancer-associated mortality and the prognosis is yet to be fully elucidated due to the paucity of effective therapeutic targets that significantly influence the quality of life and mean survival rates of patients with osteosarcoma. Studies have showed that tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yi-Jiong, Zhang, Guo-Ping, Zhao, Feng, Li, Rui-Qi, Liu, Shao-Jun, Zhao, Zeng-Ren, Wang, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792772/ https://www.ncbi.nlm.nih.gov/pubmed/29467844 http://dx.doi.org/10.3892/etm.2017.5679

Ejemplares similares

Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway
por: Su, Xuan, et al.
Publicado: (2016)

TRIM14 promotes endothelial activation via activating NF-κB signaling pathway
por: Huang, Xuan, et al.
Publicado: (2019)

TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway
por: Xu, Guoxing, et al.
Publicado: (2017)

Bmi-1-targeting suppresses osteosarcoma aggressiveness through the NF-κB signaling pathway
por: Liu, Jiaguo, et al.
Publicado: (2017)

Cyclophilin A potentiates TRIM5α inhibition of HIV-1 nuclear import without promoting TRIM5α binding to the viral capsid
por: Burse, Mallori, et al.
Publicado: (2017)

[Retracted] Bmi‑1‑targeting suppresses osteosarcoma aggressiveness through the NF‑κB signaling pathway
por: Liu, Jiaguo, et al.
Publicado: (2023)

TRIM58 Interacts with Pyruvate Kinase M2 to Inhibit Tumorigenicity in Human Osteosarcoma Cells
por: Yuan, Peng, et al.
Publicado: (2020)

miR-451a Inhibits the Growth and Invasion of Osteosarcoma via Targeting TRIM66
por: Ma, Xiao, et al.
Publicado: (2019)

Targeting METTL14 and RNA methylation to treat osteosarcoma
por: Ren, Lili, et al.
Publicado: (2022)

TRIM50 Inhibits Gastric Cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP
por: Hu, Jiajia, et al.
Publicado: (2023)

MicroRNA-16 inhibits endometrial stromal cell migration and invasion through suppression of the inhibitor of nuclear factor-κB kinase subunit β/nuclear factor-κB pathway
por: Wang, Xiaoping, et al.
Publicado: (2020)

TRIM14 Promotes Breast Cancer Cell Proliferation by Inhibiting Apoptosis
por: Hu, Gaowu, et al.
Publicado: (2019)

Nuclear Lamins and Emerin Are Differentially Expressed in Osteosarcoma Cells and Scale with Tumor Aggressiveness
por: Urciuoli, Enrica, et al.
Publicado: (2020)

Circ_0051079 silencing inhibits the malignant phenotypes of osteosarcoma cells by the TRIM66/Wnt/β-catenin pathway in a miR-625-5p-dependent manner
por: Wang, Weilin, et al.
Publicado: (2022)

TRIM14 inhibits OPTN-mediated autophagic degradation of KDM4D to epigenetically regulate inflammation
por: Liu, Di, et al.
Publicado: (2022)

TRIM37 promotes tumor cell proliferation and drug resistance in pediatric osteosarcoma
por: Tao, Yanling, et al.
Publicado: (2017)

Suppression of CLC-3 chloride channel reduces the aggressiveness of glioma through inhibiting nuclear factor-κB pathway
por: Wang, Bing, et al.
Publicado: (2017)

Upregulation of CENPF is linked to aggressive features of osteosarcoma
por: Zou, Ping-An, et al.
Publicado: (2021)

TRIM14 Promotes Noncanonical NF‐κB Activation by Modulating p100/p52 Stability via Selective Autophagy
por: Chen, Meixin, et al.
Publicado: (2019)

MicroRNA-873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β-catenin pathway
por: Liu, Yilin, et al.
Publicado: (2022)

TRIM31 promotes glioma proliferation and invasion through activating NF-κB pathway
por: Zhou, Li, et al.
Publicado: (2019)

TRIM14 promotes cell proliferation and inhibits apoptosis by suppressing PTEN in colorectal cancer
por: Shen, Weidong, et al.
Publicado: (2019)

[Retracted] Upregulation of CENPF is linked to aggressive features of osteosarcoma
por: Zou, Ping-An, et al.
Publicado: (2023)

TRIM14 expression is regulated by IRF‐1 and IRF‐2
por: Cui, Jingang, et al.
Publicado: (2019)

TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling
por: Liu, Wei, et al.
Publicado: (2022)

TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK/ERK signaling
por: Xia, Kezhou, et al.
Publicado: (2023)

Loss of ATRX promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin binding
por: Bartholf DeWitt, Suzanne, et al.
Publicado: (2022)

TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα
por: Ji, Jianxiong, et al.
Publicado: (2020)

TRIM16 suppresses the progression of prostate tumors by inhibiting the Snail signaling pathway
por: Qi, Li, et al.
Publicado: (2016)

TRIM16 suppresses the progression of prostate tumors by inhibiting the Snail signaling pathway
por: Qi, Li, et al.
Publicado: (2023)

MicroRNA-939-5p directly targets IGF-1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway
por: Zhao, Xiwu, et al.
Publicado: (2019)

MicroRNA-939-5p directly targets IGF-1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway
por: Zhao, Xiwu, et al.
Publicado: (2022)

Overexpression of p62 is associated with poor prognosis and aggressive phenotypes in osteosarcoma
por: Lu, Yao, et al.
Publicado: (2018)

TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome
por: Chen, Yu, et al.
Publicado: (2015)

Downregulation of TACC3 inhibits tumor growth and migration in osteosarcoma cells through regulation of the NF-κB signaling pathway
por: Zhao, Congran, et al.
Publicado: (2018)

Changes of Nuclear Matrix Proteins Following the Differentiation of Human Osteosarcoma MG-63 Cells
por: Zhao, Chun-Hong, et al.
Publicado: (2006)

The SUMOylation of TAB2 mediated by TRIM60 inhibits MAPK/NF-κB activation and the innate immune response
por: Gu, Zhiwen, et al.
Publicado: (2020)

Inhibition of Influenza A Virus Replication by TRIM14 via Its Multifaceted Protein–Protein Interaction With NP
por: Wu, Xiangwei, et al.
Publicado: (2019)

TRIM44, a crucial target of miR-410, functions as a potential oncogene in osteosarcoma
por: Wang, Heng, et al.
Publicado: (2018)

Knockdown of MCM8 functions as a strategy to inhibit the development and progression of osteosarcoma through regulating CTGF
por: Ren, Zhinan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_44mge26dchac49rmt9jcpc5ucc